Bronchiolitis Obliterans Syndrome (BOS) Recruiting Phase 1 Trials for Itacitinib (DB12154)

Also known as: Obliterative Bronchiolitis / Bronchiolitis Obliterans / Bronchiolitis Obliterans (BO) / Bronchiolitis Obliterans Syndrome / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0071683 (Bronchiolitis Obliterans Syndrome (BOS))Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04239989Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell TransplantTreatment